Artelo Biosciences Inc. (ARTL) Fundamentals

Artelo Biosciences Inc is a United States based development-stage biopharmaceutical company. It is focused on discovering, licensing, developing and commercializing treatments that control the endocannabinoid system. The company seeks to pursue technologies and programs that offer proprietary approaches to cannabinoid-based therapies, including those derived from the cannabis plant and synthetic cannabinoids, as well as new chemical entities and compounds that promote the effectiveness of the endocannabinoid system. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare and orphan disease.
SHARE INFORMATION
Market Cap$ 7,253,448
Shares Outstanding2,855,688
Float2,831,365
Percent Float99.15%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -6.00
Latest Fiscal Date2021-08-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions17
Institutional Holdings Date2022-10-31
Institutional Bought Previous 3 Months23,840
Institutional Holdings Percent9.3%
Institutional Sold Previous 3 Months-
Insider Holdings Date2022-10-31
Insider Bought Previous 3 Months2,400
Insider Holdings Percent33.0
Insider Sold Previous 3 Months-
Insider Shares Owned938,037
TRADING INFO
52 Week High$ 11.55
52 Week Low$ 2.38
52 Week High Change$ -76.51
21 Day Moving Average$ 2.7722
21 Day Extended Moving Average$ 2.7718
50 Day Moving Average$ 3.1125
50 Day Extended Moving Average$ 3.1382
200 Day Moving Average$ 4.806
200 Day Extended Moving Average$ 5.2231
10 Day Average Volume26,055
20 Day Average Volume19,495
30 Day Average Volume18,743
50 Day Average Volume19,751
Alpha-0.044961
Beta1.1654
Standard Deviation0.227216
R20.074842
7 Day Price Change$ -0.33
7 Day Percent Change-11.5%
21 Day Price Change$ -0.31
21 Day Percent Change-10.88%
30 Day Price Change$ -0.31
30 Day Percent Change-10.88%
Month to Date Price Change$ -0.33
Month to Date Percent Change-11.5%
Quarter to Date Price Change$ -0.91
Quarter to Date Percent Change-26.38%
180 Day Price Change$ -2.52
180 Day Percent Change-49.75%
200 Day Price Change$ -2.85
200 Day Percent Change-52.91%
Year to Date Price Change$ -5.25
Year to Date Percent Change-67.37%

Artelo Biosciences Inc. (ARTL) Key Ratios

PROFITABILITY
EBIT Margin0.0%
EBITDA Margin0.0%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.40
Total Debt To Equity0.00
Int Coverage-2,154.80
Current Ratio42.30
Leverage Ratio1.00
Quick Ratio40.60
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-0.60
Enterprise Value$ -12,498,236
Price to Sales0.00
Price to Free Cash-0.80
PE High Last 5 Years0.00
Price To Book0.30
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book0.40
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-61.51
Return on Equity-63.51
Return on Capital-34.52

Artelo Biosciences Inc. (ARTL) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorMaloneBailey, LLP
CEOGregory D. Gorgas
Emplyoees2
Last AuditUQ
CIK0001621221
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address888 Prospect Street
Suite 210
San Diego, CA 92037
Websitehttp://www.artelobio.com
Facsimile-
Telephone+1 760 943-1689
Email-


Your Recent History
NASDAQ
ARTL
Artelo Bio..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.